PCG
RGNX icon

Private Capital Group’s Regenxbio RGNX Stock Holding History

Private Capital Group’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$0 Hold
14
– – ﹤0.01% 2064
2022
Q1 		$1K Hold
14
– – ﹤0.01% 1991
2021
Q4 		$1K Hold
14
– – ﹤0.01% 1982
2021
Q3 		$1K Buy
+14
New +$504 ﹤0.01% 2047
2020
Q3 		– Sell
-65
Closed -$2K – 2089
2020
Q2 		$2K Buy
65
+25
+63% +$932 ﹤0.01% 1718
2020
Q1 		$1K Buy
40
+4
+11% +$167 ﹤0.01% 1853
2019
Q4 		$1K Buy
36
+12
+50% +$474 ﹤0.01% 1843
2019
Q3 		$1K Buy
+24
New +$972 ﹤0.01% 2082
2019
Q2 		– Sell
-6
Closed – – 2387
2019
Q1 		$0 Hold
6
– – ﹤0.01% 2298
2018
Q4 		$0 Buy
+6
New +$352 ﹤0.01% 2313

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

Private Capital Group's RGNX Position: Q2 2022 in Review

Private Capital Group held its Regenxbio (RGNX) position steady in Q2 2022 at 14 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2064.

Private Capital Group first reported a position in RGNX in Q4 2018 and has held it in 10 quarters since. The position peaked at $2K in Q2 2020. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2022.

  • Private Capital Group held 14 shares of Regenxbio worth $0 as of Q2 2022.
  • Private Capital Group left its Regenxbio share count unchanged in Q2 2022.
  • Regenxbio made up ﹤0.01% of Private Capital Group's portfolio in Q2 2022, its #2064 holding.
  • Private Capital Group first reported a position in Regenxbio in Q4 2018 and has held it in 10 quarters since.
  • Private Capital Group's Regenxbio position peaked at $2K in Q2 2020.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.